Dropping Names and Dropping Weight: The obesity paradox and new cholesterol guidelines


Subscribe on iTunes

This week: Cardiovascular Disease and Population Health

Fahad and Amol want you to:

1. Understand that high quality evidence now demonstrates that obesity does not confer a survival benefit in Type 2 Diabetes, and patients should aim to achieve a normal body weight.

2. Recognize that the new cholesterol guidelines move away from specific lipid targets and recommend statin therapy for an increased number of adult patients.

Continuing Medical Education

Internists can receive 0.5 hours of Continuing Medical Education credit for each podcast they listen to through the Canadian Society of Internal Medicine (MOC Category 1) and the American Medical Association (PRA Category 1). To receive CME credit for listening to this podcast, please click here to fill out our Evaluation and Impact Assessment Form.

The papers

Deirdre K. Tobias et al. Body-Mass Index and Mortality among Adults with Incident Type 2 Diabetes. N Engl J Med 2014; 370:233-244

Michael J. Pencina et al. Application of New Cholesterol Guidelines to a Population-Based Sample. N Engl J Med 2014; 370:1422-1431

Additional articles mentioned:

Mercedes R. Carnethon et al. Association of Weight Status With Mortality in Adults With Incident Diabetes. JAMA. 2012;308(6):581-590.

Ed Silverman. The New Cholesterol Guidelines and Conflicts of Interest. Forbes.com, Nov 20, 2013.

Good stuff

Fahad:

India’s Particulate Problem, Michael Greenstone and Rohini Pande, New York Times, February 9, 2014.

Amol:

A Day In The Life Of A Patient: Why Can’t We Do Better, Harlan Krumholz, Forbes.com, September 19, 2013. 

Reducing the Trauma of Hospitalization, Allan S. Detsky and Harlan Krumholz, JAMA, May 1, 2014. 

Leave a Comment